All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q3 report for ELANCO ANIMAL HEALTH on October 19, 2026, reporting $140,000 in lobbying income.

Lobbying for ELANCO ANIMAL HEALTH · Animal pharmaceutical company

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything ELANCO ANIMAL HEALTH has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$140,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Advocacy surrounding the development of pharmaceuticals for animals

Tariff (miscellaneous tariff bills)

Advocacy surrounding tariff policy for animal pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem